US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.8490
  • 0.00000.00%
Close Aug 14 16:00 ET
  • 0.8500
  • +0.0010+0.12%
Post 20:02 ET
4.15MMarket Cap-64P/E (TTM)

Virpax Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
6.76%3.46M
100.02%3.3M
-22.46%16.94M
91.29%5.93M
-20.74%6.12M
-45.13%3.24M
-67.78%1.65M
81.66%21.85M
-24.74%3.1M
137.41%7.72M
Selling and administrative expenses
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
216.46%4.91M
-General and administrative expense
-22.91%1.5M
306.59%1.69M
6.67%11.82M
177.38%4.84M
-5.92%4.62M
-26.34%1.95M
-76.69%415.45K
54.21%11.08M
-26.47%1.74M
216.46%4.91M
Research and development costs
51.54%1.96M
30.56%1.61M
-52.45%5.12M
-19.30%1.1M
-46.68%1.5M
-60.39%1.29M
-63.02%1.24M
122.41%10.76M
-22.39%1.36M
65.18%2.81M
Operating profit
-6.76%-3.46M
-100.02%-3.3M
22.46%-16.94M
-91.29%-5.93M
20.74%-6.12M
45.13%-3.24M
67.78%-1.65M
-81.66%-21.85M
24.74%-3.1M
-137.41%-7.72M
Net non-operating interest income expense
-11K
0
Non-operating interest expense
--11K
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-84.91%19.13K
-37.15%82.03K
800.29%1.75M
1,093.69%1.37M
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
Special income (charges)
----
----
--1.25M
----
----
----
----
----
----
----
-Less:Other special charges
----
----
---1.25M
----
----
----
----
----
----
----
Other non- operating income (expenses)
-84.91%19.13K
-37.15%82.03K
157.33%500.28K
6.45%122.39K
64.69%120.64K
554.07%126.72K
1,090.15%130.53K
212.26%194.41K
3,526.81%114.97K
16.42%73.25K
Income before tax
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
Income tax
0
0
0
0
0
0
0
0
Net income
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
Net income continuous Operations
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
Minority interest income
Net income attributable to the parent company
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
-137.64%-7.64M
Basic earnings per share
34.21%-1.75
-111.54%-2.75
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.80%-2.66
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
Diluted earnings per share
34.21%-1.75
-111.54%-2.75
29.85%-12.97
-49.42%-3.87
21.54%-5.1
46.80%-2.66
70.45%-1.3
-2.15%-18.49
26.31%-2.59
-22.64%-6.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 6.76%3.46M100.02%3.3M-22.46%16.94M91.29%5.93M-20.74%6.12M-45.13%3.24M-67.78%1.65M81.66%21.85M-24.74%3.1M137.41%7.72M
Selling and administrative expenses -22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M216.46%4.91M
-General and administrative expense -22.91%1.5M306.59%1.69M6.67%11.82M177.38%4.84M-5.92%4.62M-26.34%1.95M-76.69%415.45K54.21%11.08M-26.47%1.74M216.46%4.91M
Research and development costs 51.54%1.96M30.56%1.61M-52.45%5.12M-19.30%1.1M-46.68%1.5M-60.39%1.29M-63.02%1.24M122.41%10.76M-22.39%1.36M65.18%2.81M
Operating profit -6.76%-3.46M-100.02%-3.3M22.46%-16.94M-91.29%-5.93M20.74%-6.12M45.13%-3.24M67.78%-1.65M-81.66%-21.85M24.74%-3.1M-137.41%-7.72M
Net non-operating interest income expense -11K0
Non-operating interest expense --11K------------------0----------------
Other net income (expense) -84.91%19.13K-37.15%82.03K800.29%1.75M1,093.69%1.37M64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K16.42%73.25K
Special income (charges) ----------1.25M----------------------------
-Less:Other special charges -----------1.25M----------------------------
Other non- operating income (expenses) -84.91%19.13K-37.15%82.03K157.33%500.28K6.45%122.39K64.69%120.64K554.07%126.72K1,090.15%130.53K212.26%194.41K3,526.81%114.97K16.42%73.25K
Income before tax -10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M
Income tax 00000000
Net income -10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M
Net income continuous Operations -10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M
Minority interest income
Net income attributable to the parent company -10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M-137.64%-7.64M
Basic earnings per share 34.21%-1.75-111.54%-2.7529.85%-12.97-49.42%-3.8721.54%-5.146.80%-2.6670.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5
Diluted earnings per share 34.21%-1.75-111.54%-2.7529.85%-12.97-49.42%-3.8721.54%-5.146.80%-2.6670.45%-1.3-2.15%-18.4926.31%-2.59-22.64%-6.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg